Moderator: Allen S. Chen, MD, MPH
149. Results of the degenerate-disc infection study with contaminant control (DISC) study
Prashanth J. Rao, PhD, MD1; Monish M. Maharaj, MD, MS2; Kevin Phan, BS3; Ralph J. Mobbs, MD, FRACS4
1Prince of Wales Private Hospital, Sydney, Australia; 2NeuroSpine Clinic, Sydney, New South Wales, Australia; 3Sydney, Australia; 4Prince of Wales Private Hospital, Neurosurgery & NSURG Group, Randwick, NSW, Australia
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
150. Examining the relationship between epidural steroid injections and patient satisfaction
Trevor R. Mordhorst, MS, BA1; Zachary McCormick, MD2; Darrel S. Brodke, MD2; Angela Presson; Willem H. Collier, BS3; W. Ryan Spiker, MD4
1University of Washington, Seattle, WA, US; 2University Orthopaedic Center, Salt Lake City, UT, US; 3University of Utah, Salt Lake City, UT, US; 4University of Utah Orthopaedics, Salt Lake City, UT, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
151. Efficacy of transforaminal steroid injections to prevent surgical treatment for patients with cervical radiculopathy
Swamy Kurra, MD1; Brandon A. Simonetta, MD2; Suehun G. Ho, MD3; Richard A. Tallarico, MD4; William F. Lavelle, MD4
1Syracuse, NY, US; 2Orlando, FL, US; 3UPMC, Pittsburgh, PA, US; 4Upstate Orthopedics, East Syracuse, NY, US
FDA Device/Drug Status: Epidural spinal injection (Approved for this indication)
152. Stem cell therapy for pressure injury: A pilot study with autologous bone marrow derived stem cell (BM-MNC)
Rajeshwar N. Srivastava, MD1; Mukesh K. Dwivedi, PhD, PhD2; Amit K. Bhagat, PhD1; Lavini Raj, BS1
1King George's Medical University, Department of Orthopaedic Surgery, Lucknow, Uttar Pradesh, India; 2Department of Orthopaedic Surgery, Lucknow, Uttar Pradesh, India
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
153. Can cervical transforaminal epidural steroid injections be surgery sparing?
Kush K. Goyal, MD1; Matthew L. Abbott2
1Cleveland Clinic - Lutheran, Cleveland, OH, US; 2Cleveland, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
154. Back pain of degenerative scoliotic patients treated with triple modalities guided radiofrequency ablation-case series with preliminary results
Ting-Chun Huang, MD
National Taiwan University Hospital Chu-Tung Branch, Hsinchu County, Taiwan
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
155. Interspinous process decompression with the Superion® Spacer for lumbar spinal stenosis: real world experience from a device registry
Gene Tekmyster, DO1; Dawood Sayed, MD2; Kevin D. Cairns, MD3; Louis J. Raso, MD4; Jon Block
1Orthopaedic and Sports Medicine Center, Trumbull, CT, US; 2University of Kansas Medical Center, Kansas City, KS, US; 3Florida Spine Specialists, Fort Lauderdale, FL, US; 4Jupiter, FL, US
FDA Device/Drug Status: Superion Indirect Decompression System (Approved for this indication)
Discussion